Skip to content
20-F

Annual Report (Foreign)

Orphazyme A/S

0001564590-22-024528

← back to feed
Filed
Jun 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2021 · Dec 31, 2021 34.92M sh
Shares Diluted FY 2021 · Dec 31, 2020 28.37M sh
Shares Diluted FY 2021 · Dec 31, 2019 20.02M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −602.57M
Operating Cash Flow FY 2021 · Dec 31, 2020 −539.08M
Operating Cash Flow FY 2021 · Dec 31, 2019 −326.82M
Cash And Equivalents FY 2021 · Dec 31, 2021 102.26M
Cash And Equivalents FY 2021 · Dec 31, 2020 726.93M
Cash And Equivalents FY 2021 · Dec 31, 2019 123.59M
Cash And Equivalents FY 2021 · Dec 31, 2018 394.71M
Stockholders Equity FY 2021 · Dec 31, 2021 9.34M
Stockholders Equity FY 2021 · Dec 31, 2020 620.53M
Stockholders Equity FY 2021 · Dec 31, 2019 52.97M
Stockholders Equity FY 2021 · Dec 31, 2018 388.25M
Current Liabilities FY 2021 · Dec 31, 2021 129.09M
Current Liabilities FY 2021 · Dec 31, 2020 166.63M
Current Assets FY 2021 · Dec 31, 2021 158.94M
Current Assets FY 2021 · Dec 31, 2020 783.66M
Total Assets FY 2021 · Dec 31, 2021 173.23M
Total Assets FY 2021 · Dec 31, 2020 822.49M
Rd Expense FY 2021 · Dec 31, 2021 329.98M
Rd Expense FY 2021 · Dec 31, 2020 361.28M
Rd Expense FY 2021 · Dec 31, 2019 285.41M
Net Income FY 2021 · Dec 31, 2021 −626.54M
Net Income FY 2021 · Dec 31, 2020 −633.25M
Net Income FY 2021 · Dec 31, 2019 −337.5M
Operating Income FY 2021 · Dec 31, 2021 −633.3M
Operating Income FY 2021 · Dec 31, 2020 −608.53M
Operating Income FY 2021 · Dec 31, 2019 −335.95M
Revenue FY 2021 · Dec 31, 2021 36.19M
Revenue FY 2021 · Dec 31, 2020 0
Revenue FY 2021 · Dec 31, 2019 0